Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dysphagia, SARS-CoV-2 test
Clinical narrative: could not swallow; covid 19. Severe sore throat, Problem breathing; This spontaneous case was reported by a consumer and describes the occurrence of DYSPHAGIA (could not swallow) and COVID-19 (covid 19. Severe sore throat, Problem breathing) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002C21A, 026620A and 006M20A) for COVID-19 prophylaxis.     Patient had no past medical history and allergies and also did not had any history relating to mentioned adverse event and both acute and chronic illnesses at the time of vaccination. Patient had no other vaccination prior to Moderna COVID-19 vaccine.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Sep-2022, the patient experienced DYSPHAGIA (could not swallow) (seriousness criterion hospitalization). 13-Sep-2022, the patient experienced COVID-19 (covid 19. Severe sore throat, Problem breathing) (seriousness criterion hospitalization). The patient was hospitalized from 13-Sep-2022 to 30-Oct-2022 due to COVID-19 and DYSPHAGIA. At the time of the report, DYSPHAGIA (could not swallow) and COVID-19 (covid 19. Severe sore throat, Problem breathing) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Sep-2022, SARS-CoV-2 test: Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Patient had primary and booster dose on 2021.  Patient was hospitalized from 13Sep2022 to 30Oct2022 for Covid-19. It was reported that patient was hospitalized for 3 times. It was reported that she must wait 5 weeks before he could get the booster. She wanted to know if that is correct since her husband and her had severe COVID 19 and was hospitalize. She also wanted to know if you was not severely sick with COVID could she still take the vaccine.  On 13-Sep-2022, patient had severe sore throat and problem breathing as symptom of covid-19.  It was reported that health care professional was aware of the events.  Patient received unspecified treatment for the events.  Company comment: This spontaneous case reported by a consumer concerns a female patient of unknown age, with no relevant medical history reported, who experienced the unexpected serious(Hospitalization) events of DYSPHAGIA and COVID-19 (covid 19. Severe sore throat, Problem breathing),about 10 months after receiving the 3 dose of  mRNA-1273 vaccine in the covid 19 vaccination series. Previous vaccination doses included 2 doses of Moderna vaccine at an appropriate interval, about 08 months prior to the current dose. On the date of event onset, SARS-CoV-2 test was Positive. No further information on comorbidities, risk factors, medical history, symptoms, labs and diagnostic procedures, clinical course and concomitant medications was available in the report. Patient received unspecified treatment for the events. Ongoing Covid 19 pandemia is a confounder. The events were resolving. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report. Event seriousness assessed per medical judgement.; Sender's Comments: This spontaneous case reported by a consumer concerns a female patient of unknown age, with no relevant medical history reported, who experienced the unexpected serious(Hospitalization) events of DYSPHAGIA and COVID-19 (covid 19. Severe sore throat, Problem breathing),about 10 months after receiving the 3 dose of  mRNA-1273 vaccine in the covid 19 vaccination series. Previous vaccination doses included 2 doses of Moderna vaccine at an appropriate interval, about 08 months prior to the current dose. On the date of event onset, SARS-CoV-2 test was Positive. No further information on comorbidities, risk factors, medical history, symptoms, labs and diagnostic procedures, clinical course and concomitant medications was available in the report. Patient received unspecified treatment for the events. Ongoing Covid 19 pandemia is a confounder. The events were resolving. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report. Event seriousness assessed per medical judgement.